Albertsons Companies, Inc. (NYSE: ACI) Q2 2025 Earnings Call | 10/14/2025Description:

Key Financial Highlights:

• Identical Sales: Adjusted identical sales grew 2.2%, despite a 12 basis point negative impact from a three-week Colorado labor dispute affecting 47 stores.
• Adjusted EBITDA: $848 million, in line with expectations.
• Adjusted EPS: $0.44 per diluted share.
• Gross Margin: 27% (excl. fuel and MIPO), down 63 basis points year-over-year due to a mix shift toward digital and pharmacy, partially offset by productivity gains.
• Selling and Administrative Expense Rate: Improved 50 basis points year-over-year (excl. fuel), driven by employee cost leverage and lower merger-related expenses.
• Interest Expense: $105 million, up slightly from $103 million due to refinancing costs for a $4 billion asset-based credit facility extended to 2030.
• Capital Allocation:
  • Increased share repurchase authorization from $2 billion to $2.75 billion.
  • Executed a $750 million accelerated share repurchase (ASR), representing ~8% of outstanding shares, in addition to $600 million repurchased year-to-date (total ~12% of shares).
  • Post-ASR net debt to adjusted EBITDA ratio at 2.2x, maintaining operational flexibility.
• Labor Negotiations: Reached agreements for 107,000 of 120,000 associates up for renewal in 2025.
• Store Actions: Announced closure of 29 underperforming stores and plans to open 9 new stores by year-end.
• Real Estate Portfolio: $14.3 billion portfolio appraised in July 2025, supporting operational and growth strategies.

Strategic and Operational Updates:

• “A New Day at Albertsons” Mindset: Emphasizes bold decisions, customer centricity, and long-term sustainable growth.
• Five Strategic Priorities:
  1. Digital Connection: E-commerce grew 23% year-over-year, with a 24% CAGR over three years. Loyalty membership grew 13% to 48 million, with 40% of engaged households opting for cash-off rewards.
  2. Media Collective: Strong momentum with improved ad spend returns, driven by enhanced data quality, precise targeting, and new channels like shoppable recipes and in-store digital signage.
  3. Customer Value Proposition: Surgical price investments, loyalty enhancements, and own brands (targeting 25% to 30% penetration) drive engagement and margin accretion.
  4. Technology Modernization: Cloud-native platform and AI (e.g., Ask AI feature, OpenAI partnership) enhance personalization, merchandising, and operational efficiency.
  5. Transformational Productivity: On track for $1.5 billion in savings from 2025–2027, primarily SG&A in 2025, with future margin expansion via better purchasing and AI-driven merchandising.
• E-commerce: Store-based fulfillment model leverages proximity to customers, enabling fast delivery (e.g., 30-minute flash delivery) and nearing breakeven profitability.
• Pharmacy: 19% year-over-year growth, driven by GLP-1s, core prescription volume, and share gains from competitor closures. Cross-channel shoppers (grocery + pharmacy) show higher lifetime value.
• Own Brands: New offerings enhance value and margins, with a goal to increase penetration.
• Productivity Initiatives: Include AI cameras for shrink reduction, automation, offshore operations (India Technology Center, Manila back-office), and national buying strategies.
• Real Estate Strategy: Evaluating assets to optimize footprint, with data-driven decisions on store performance, banner consolidation, and market expansion via organic growth or acquisitions.

Updated Fiscal 2025 Outlook:

• Identical Sales: Raised to 2.2%–2.75%, driven by pharmacy and digital growth, with surgical price investments.
• Adjusted EBITDA: Unchanged at $3.8–$3.9 billion, including ~$65 million from a 53rd week in Q4.
• Adjusted EPS: Raised to $2.06–$2.19, reflecting ASR accretion.
• Tax Rate: 23.5%–24.5%, with a $125–$150 million cash flow benefit from tax legislation.
• Capital Expenditures: Increased to $1.8–$1.9 billion to accelerate digital and automation investments.
• Tariffs: Minimal impact (90% of products domestically sourced), with proactive supplier strategies to mitigate costs.

Q&A Highlights:

• Long-Term Growth (2026 Algorithm): Confidence in returning to 2%+ identical sales in 2026, driven by pharmacy, e-commerce, and productivity savings. Unit sales expected to approach flat, with pharmacy and e-commerce improving profitability.
• Price Investments: Surgical by category/market, offset by vendor funding and productivity. No aggressive price cuts planned; loyalty and own brands enhance perceived value.
• Consumer Trends: Focus on value (smaller packages, own brands, coupons), with growth in healthier categories (fresh meat, produce, functional beverages).
• Pharmacy Cross-Selling: GLP-1 customers initially reduce basket size but recover quickly, expanding into margin-accretive categories. New and existing customers drive growth.
• E-commerce Profitability: Nearing breakeven via optimized picking paths, store retrofits, and proximity-based fulfillment.
• AI Integration: Involves associates in tool development for intuitive use (e.g., merchandising, order planning). AI supports real-time analytics for real estate and merchandising decisions.
• Asset Strategy: Data-driven evaluation of store performance and banner consolidation (e.g., flipping Albertsons to Safeway in Northwest). Targeting fill-in acquisitions in high-growth markets.
• Shrink Reduction: Improved via AI cameras, order management, and production planning, contributing to profitability.